Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker TTRX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 9, 2026 | TTRX Turn Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 7, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 10, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 9, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 18, 2026 | TTRX Turn Therapeutics Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Aug 17, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2026 | TTRX Turn Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 28, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 7, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 3, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 1, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 27, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 19, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 18, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 11, 2026 | TTRX Turn Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 31, 2026 | TTRX Turn Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 24, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 24, 2026 | TTRX Turn Therapeutics Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 24, 2026 | TTRX Turn Therapeutics Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Mar 24, 2026 | TTRX Turn Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 17, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 9, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 7, 2026 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 7, 2026 | TTRX Turn Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 13, 2025 | TTRX Turn Therapeutics Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2025 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 4, 2025 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 30, 2025 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 28, 2025 | TTRX Turn Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 22, 2025 | TTRX Turn Therapeutics Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 2, 2025 | TTRX Turn Therapeutics Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 2, 2025 | TTRX Turn Therapeutics Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 2, 2025 | TTRX Turn Therapeutics Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Oct 2, 2025 | TTRX Turn Therapeutics Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
36 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 16, 2026, 9:43 AM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances